Sign in
Taking peopleNo phase

Outcomes of Polish response teams treating sudden blood clots in the lungs

Describes care and results for adults with acute pulmonary embolism treated by Polish specialist teams.

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Polish Multicenter PERTs PE Outcomes Registry
Status
Recruiting
People taking part
10,000 people, planned
Started
1 Jun 2018
Expected to end
Dec 2030
Type of study
Observational, 2 groups
Record updated
10 May 2021

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a sudden blood clot in the lungs (acute pulmonary embolism) treated by Polish PE response teams. It records how they are treated and how they do.

Age
18 Years and older
Sex
All
Disease stage
PE confirmed by computed tomography pulmonary angiography, with symptoms for ≤ 14 days. It must be high-risk PE with unstable blood pressure or circulation (cardiac arrest, obstructive shock or persistent low blood pressure), or intermediate-high risk PE.
Biomarker or test result
For intermediate-high risk PE: strain of the right side of the heart seen on imaging and a raised troponin level in the blood.

Main reasons for not taking part

  • Refusing to sign the informed consent form

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • PE confirmed by computed tomography pulmonary angiography
  • PE symptoms duration ≤ 14 days
  • High-risk PE with hemodynamic instability (one of):; cardiac arrest; obstructive shock; persistent hypotension
  • Intermediate-high risk PE patients with right ventricle dysfunction confirmed by imaging studies and elevated troponin level

Who cannot take part

  • Refusal to sign the informed consent form

This trial is currently available in Poland.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving outcomes for patients with PE. All institutionalized PERTs in Poland have been invited to join the study. The goal of this registry is to describe current practice and outcomes in patients with acute PE treated by Polish PERTs.

The 2 groups in the trial

  • Intermediate-high risk PE

    Confirmed PE causing right ventricle dysfunction confirmed by computed tomography pulmonary angiography or transthoracic echocardiography and elevated troponin level

  • High-risk PE

    Confirmed PE causing hemodynamic instability: 1. Cardiac arrest (need for cardiopulmonary resuscitation) or, 2. Obstructive shock (systolic blood pressure \< 90 mmHg or vasopressors required to achieve a systolic blood pressure ≥90 mmHg despite adequate filling status and end-organ hypoperfusion), or 3. Persistent hypotension (systolic blood pressure \< 90 mmHg for at least 15 minutes)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Polish Multicenter Pulmonary Embolism Response Teams Outcomes Registry
Plain-language title
Outcomes of Polish response teams treating sudden blood clots in the lungsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Publications
Record updated
10 May 2021